SILDENAFIL PAH-Mepha cpr pell 20 mg 90 pce

7680664520019 CH-66452 G04BE03 02.07.1.

Reimbursement limitations:

SILDEN.P.MEP

Garantie de prise en charge des coûts par l'assureur-maladie après consultation préalable du médecin-conseil sur …

SILDENAFIL PAH-Mepha cpr pell 20 mg 90 pce
SILDENAFIL PAH-Mepha cpr pell 20 mg 90 pce
SILDENAFIL PAH-Mepha cpr pell 20 mg 90 pce
1 / 3
google

Details

Product number
6645201
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
sildenafilum 20 mg ut sildenafili citras, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium 0.54 mg, magnesii stearas, Überzug: hypromellosum, macrogolum 6000, talcum, E 171, pro compresso obducto.

Articles (1)

Sildenafil PAH-Mepha 20 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/02/2024
Patient information leaflet
Français
15/02/2024
Patient information leaflet
Italien
15/02/2024
Professional SmPC
Allemand
07/02/2024
Professional SmPC
Français
07/02/2024
Professional SmPC
Italien
07/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.54 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 512.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66452
Drug name
Sildenafil PAH-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
G04BE03
Authorization status
Z
Dispensation category
B
First authorization
28/04/2017
Authorization expiration date
31/12/9999
IT number
02.07.1.
Domain
Human medicine
Field of application
Behandlung der pulmonalen arteriellen Hypertonie (primäre pulmonale Hypertonie, sowie mit Bindegewebserkrankungen assoziierte PAH) der WHO-Klasse II und III, zur Verbesserung der körperlichen Leistungsfähigkeit

Packaging details

Description (FR)
SILDENAFIL PAH-Mepha cpr pell 20 mg 90 pce
Description (DE)
SILDENAFIL PAH-Mepha Filmtabl 20 mg 90 Stk
Market launch
28/04/2017
Narcotic (BTM)
No

Original drug

Revatio, Filmtabletten
CHF 522.10
View original